Skip to content | Change text size
 

Dr Natalie L Trevaskis

Image of Dr Natalie L Trevaskis

Lecturer
Research Fellow

BPharm (Hons) Monash University
PhD Monash University

Telephone: +61 3 9903 9138
Fax: +61 3 9903 9583
Email: natalie.trevaskis@pharm.monash.edu.au

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences

Research interests

  • Oral drug delivery, bioavailability enhancement and lymphatic drug transport
  • Lipid-based formulation design and assessment
  • Targeted drug delivery to lymphocytes to improve treatment of autoimmune diseases

Education

  • Lecturer in non-linear pharmacokinetics
  • Pharmaceutics tutorials (pharmacokinetics, drug delivery, biopharmaceutics and drug formulations)

Representative publications

  1. Trevaskis NL, Shackleford DM, Charman WN, Edwards GA, Gardin A, Appel-Dingemanse S, et.al. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. Pharm Res. In press 2009.
  2. Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 2008; 60(6): 702-716.
  3. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007; 6(3):231-248.
  4. Trevaskis NL, Porter CJ, Charman WN. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. J Pharmacol Exp Ther. 2006; 316(2): 881-891.
  5. Trevaskis NL, Porter CJ, Charman WN. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. Drug Metab Dispos. 2006; 34(5):729-733.
  6. Trevaskis NL, Tso P, Rider T, Charman WN, Porter CJ, Jandacek R. Tissue uptake of DDT is independent of chylomicron metabolism. Arch Toxicol. 2006; 80(4):196-200.
  7. Trevaskis NL, Lo CM, Ma LY, Tso P, Irving HR, Porter CJ, et.al. An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats. Pharm Res. 2006; 23(8):1786-1796.
  8. Trevaskis NL, Porter CJ, Charman WN. Bile increases intestinal lymphatic drug transport in the fasted rat. Pharm Res. 2005; 22(11):1863-1870.